サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1526347

デジタル・セラピューティクスの世界市場

Digital Therapeutics

出版日
ページ情報
英文 326 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.66円
デジタル・セラピューティクスの世界市場
出版日: 2024年08月05日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 326 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

デジタル・セラピューティクスの世界市場は2030年までに329億米ドルに達する見込み

2023年に57億米ドルと推定されるデジタル・セラピューティクスの世界市場は、分析期間2023-2030年にCAGR 28.6%で成長し、2030年には329億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである治療／ケアアプリケーションは、CAGR 29.1%を記録し、分析期間終了時には281億米ドルに達すると予測されます。予防アプリケーション分野の成長率は、分析期間中CAGR 26.0％と推定されます。

米国市場は23億米ドルと推定、中国はCAGR 32.2％で成長予測

米国のデジタル・セラピューティクス市場は2023年に23億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに32億米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは32.2%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ25.4%と23.6%と予測されています。欧州では、ドイツがCAGR 28.5%で成長すると予測されています。

世界のデジタル・セラピューティクス市場- 主要動向と促進要因まとめ

デジタル・セラピューティクス（DTx）は、ヘルスケア業界の変革的なセグメントであり、病状を予防、管理、治療するためのソフトウェアプログラムを通じて、エビデンスに基づく治療介入を提供することに焦点を当てています。これらの治療介入は、モバイルアプリ、デジタル機器、オンラインプラットフォームを通じて提供されることが多く、従来の治療と並行して、または単独で使用できるように設計されています。デジタル・セラピューティクスは、行動科学、人工知能、データ分析を活用し、パーソナライズされた治療計画を提供し、患者の進行状況をリアルタイムで監視し、健康状態を改善するためのフィードバックを提供します。臨床検証はデジタル・セラピューティクスの基礎であり、これらのソリューションが従来の医薬品に匹敵する有効性と安全性の厳格な基準を満たしていることを保証します。

デジタル・セラピューティクスは、糖尿病や高血圧などの慢性疾患、不安やうつなどの精神疾患など、幅広い症状に対応しています。デジタルツールを従来のヘルスケアに統合することで、DTxソリューションは、慢性疾患を効果的に管理するために不可欠な、継続的なモニタリングとリアルタイムの介入を提供することができます。また、これらのソリューションは、患者が自分の健康をよりコントロールできるようにすることで、患者のエンゲージメントを高め、治療計画のアドヒアランスを向上させます。さらに、デジタル・セラピューティクスはヘルスケアへのアクセスにおけるギャップを埋め、スケーラブルで費用対効果が高く、簡単にアクセスできるデジタルプラットフォームを通じて、十分なサービスを受けていない人々にサポートを提供することができます。ゲーミフィケーションやユーザーフレンドリーなインターフェースを取り入れることで、患者のエンゲージメントとコンプライアンスをさらに強化し、個人が治療計画を守りやすくします。

デジタル・セラピューティクス市場の成長は、いくつかの要因によってもたらされます。デジタル・セラピューティクスは、患者の転帰を大幅に改善できるオーダーメイドの介入を提供するため、慢性疾患の有病率の増加と個別化医療に対する需要の高まりが主な促進要因となっています。AI、機械学習、モバイルヘルス技術における技術的進歩は、DTxソリューションの能力とリーチを強化し、より効果的でユーザーフレンドリーにしつつあります。消費者行動も重要な促進要因であり、患者はデジタルヘルスツールをより快適に使用できるようになり、積極的な健康管理を求めるようになっています。ヘルスケアプロバイダーや保険会社による規制当局の支援とデジタル・セラピューティクスの認知は、DTxソリューションの有効性と信頼性を証明するものであり、市場をさらに後押ししています。さらに、COVID-19の流行はデジタルヘルス技術の採用を加速し、遠隔ヘルスケアソリューションの重要性を強調し、デジタル・セラピューティクス分野への投資を増加させています。これらの要因が総合的に、ヘルスケアシーンにおけるデジタル・セラピューティクスの堅調な成長と採用拡大に寄与しています。

調査対象企業の例（全136件）

  • Aptar Digital Health
  • Better Therapeutics, Inc
  • Biofourmis Inc.
  • Canary Health, Inc.
  • Click Therapeutics, Inc.
  • Fitbit Health Solutions
  • Pear Therapeutics, Inc.
  • Wellthy Therapeutics Pvt Ltd

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • 世界のその他の地域

第4章 競合

目次
Product Code: MCP11567

Global Digital Therapeutics Market to Reach US$32.9 Billion by 2030

The global market for Digital Therapeutics estimated at US$5.7 Billion in the year 2023, is expected to reach US$32.9 Billion by 2030, growing at a CAGR of 28.6% over the analysis period 2023-2030. Treatment / Care Application, one of the segments analyzed in the report, is expected to record a 29.1% CAGR and reach US$28.1 Billion by the end of the analysis period. Growth in the Preventive Application segment is estimated at 26.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.3 Billion While China is Forecast to Grow at 32.2% CAGR

The Digital Therapeutics market in the U.S. is estimated at US$2.3 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$3.2 Billion by the year 2030 trailing a CAGR of 32.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 25.4% and 23.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 28.5% CAGR.

Global Digital Therapeutics Market - Key Trends & Drivers Summarized

Digital Therapeutics (DTx) represents a transformative segment of the healthcare industry, focusing on delivering evidence-based therapeutic interventions through software programs to prevent, manage, or treat medical conditions. These interventions are often delivered via mobile apps, digital devices, and online platforms, and are designed to be used independently or alongside traditional medical treatments. Digital therapeutics leverage behavioral science, artificial intelligence, and data analytics to provide personalized treatment plans, monitor patient progress in real-time, and offer feedback to improve health outcomes. Clinical validation is a cornerstone of digital therapeutics, ensuring that these solutions meet rigorous standards of efficacy and safety comparable to traditional pharmaceuticals.

Digital therapeutics address a wide range of conditions, including chronic diseases like diabetes, hypertension, and mental health disorders such as anxiety and depression. By integrating digital tools with traditional healthcare, DTx solutions can offer continuous monitoring and real-time interventions, which are crucial for managing chronic diseases effectively. These solutions also empower patients by giving them greater control over their health, enhancing engagement and adherence to treatment plans. Additionally, digital therapeutics can bridge gaps in healthcare access, providing support to underserved populations through scalable, cost-effective, and easily accessible digital platforms. The incorporation of gamification and user-friendly interfaces further enhances patient engagement and compliance, making it easier for individuals to stick to their therapeutic regimens.

The growth in the digital therapeutics market is driven by several factors. The increasing prevalence of chronic diseases and the rising demand for personalized medicine are primary drivers, as digital therapeutics offer tailored interventions that can significantly improve patient outcomes. Technological advancements in AI, machine learning, and mobile health technologies are enhancing the capabilities and reach of DTx solutions, making them more effective and user-friendly. Consumer behavior is also a significant driver, with patients becoming more comfortable using digital health tools and seeking proactive management of their health. Regulatory support and the recognition of digital therapeutics by healthcare providers and insurers are further propelling the market, as these endorsements validate the efficacy and reliability of DTx solutions. Additionally, the COVID-19 pandemic has accelerated the adoption of digital health technologies, highlighting the importance of remote healthcare solutions and increasing investment in the digital therapeutics sector. These factors collectively contribute to the robust growth and expanding adoption of digital therapeutics in the healthcare landscape.

Select Competitors (Total 136 Featured) -

  • Aptar Digital Health
  • Better Therapeutics, Inc
  • Biofourmis Inc.
  • Canary Health, Inc.
  • Click Therapeutics, Inc.
  • Fitbit Health Solutions
  • Pear Therapeutics, Inc.
  • Wellthy Therapeutics Pvt Ltd

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Digital Therapeutics is Poised to Benefit from the Increasingly Robust Outlook for Digital Health
    • Digital Healthcare Sets the Stage for the Rise of Digital Therapeutics: Global Market for Digital Health (In US$ Billion) for Years 2023, 2025, and 2027
    • Global Economic Update
    • Competition
    • Digital Therapeutics - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Digital Therapeutics: Overview & Market Outlook
    • Recent Market Activity
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Global Focus on Meeting Unmet Needs in Mental Healthcare to Benefit Growth of Digital Therapeutics
    • Shockingly High Burden of Mental Disorders & the Ensuing Focus to Meet Unmet Care Needs Primes Digital Therapeutics for Mass Adoption: Global Economic Cost of Mental Illnesses (In US$ Trillion) for Years 2023, 2025, 2027, 2029 & 2031
    • Artificial Intelligence to Play a Key Role in Improving the Effectiveness of Digital Therapeutics
    • High Prevalence of Chronic Diseases and Growing Focus Long-Term Management & Preventative Healthcare Widens Growth Opportunities
    • Rising Prevalence of Chronic Diseases Amplifies the Need for Addressing Management of These Diseases Through Digital Therapeutics: Global Cost of Chronic Diseases (In US$ Trillion) for the Years 2023, 2025, 2027, 2029 and 2031
    • Here's How Digital Therapeutics Can Help Improve Clinical Outcomes Across the Cardiac Continuum
    • Global Annual Medical Cost of Cardiovascular Diseases in US$ Billion (2010-2030)
    • How Digital Therapeutics is Changing the Oncology Care Landscape?
    • Worrisome Epidemic Increase in Cancer Incidence to Help Accelerate Adoption of Digital Therapeutics: Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
    • Rise of mHealth & Smart Medical Devices & Wearables Paves the Way for More Spontaneous Adoption of Digital Therapeutics
    • Growing Familiarity with mHealth & Use of Medical Wearables Means There is One Less Obstacle in the Implementation of Digital Therapeutics: Global Market for mHealth & Medical Wearables (In US$ Billion) for Years 2023, 2025, 2027, 2029 and 2031
    • As Healthcare Costs Continue to Spiral, Growing Much Faster Than National GDP, Focus Shifts to Digital Therapeutics for its Ability to Lower Cost of Care
    • Growing Urgency to Rein-in Spiraling Healthcare Costs Leads Healthcare Community to Take a Closer Look at Digital Therapeutics: Healthcare Costs as a % of GDP by Country 2020 VS 2023
    • Growing Preference for Personalized Medicine Doubles the Focus on Digital Therapeutics
    • Robust Outlook for Personalized Medicine to Create a Parallel Opportunity for Digital Therapeutics: Global Market for Personalized Medicines (In US$ Billion) for Years 2023 2025, 2027, 2029 and 2031
    • Here's How AR/VR Technologies are Changing the Future of Digital Therapeutics
    • The Many Benefits of 5G in Healthcare to Catalyze Adoption of Digital Therapeutics
    • Rapid Penetration of 5G Will Make Implementation of Digital Therapeutics Seamless & More Efficient to Use: Global 5G Subscription (In Million) for Years 2023, 2025, 2027 and 2029
    • Technology and Innovation to Continue to Drive Adoption of Digital Therapeutics
    • Cybersecurity Storms Into the Spotlight. Here's Why
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Digital Therapeutics Market Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Digital Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World 7-Year Perspective for Digital Therapeutics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for B2B by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World 7-Year Perspective for B2B by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for B2C by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 7: World 7-Year Perspective for B2C by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Treatment / Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World 7-Year Perspective for Treatment / Care by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Preventive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World 7-Year Perspective for Preventive by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Digital Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 12: USA Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 13: USA 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2024 & 2030
    • TABLE 14: USA Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 15: USA 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2024 & 2030
  • CANADA
    • TABLE 16: Canada Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 17: Canada 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2024 & 2030
    • TABLE 18: Canada Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 19: Canada 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2024 & 2030
  • JAPAN
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Japan 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2024 & 2030
    • TABLE 22: Japan Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 23: Japan 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2024 & 2030
  • CHINA
    • TABLE 24: China Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 25: China 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2024 & 2030
    • TABLE 26: China Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: China 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2024 & 2030
  • EUROPE
    • Digital Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 28: Europe Recent Past, Current & Future Analysis for Digital Therapeutics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 29: Europe 7-Year Perspective for Digital Therapeutics by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
    • TABLE 30: Europe Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 31: Europe 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2024 & 2030
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Europe 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2024 & 2030
  • FRANCE
    • TABLE 34: France Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 35: France 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2024 & 2030
    • TABLE 36: France Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 37: France 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2024 & 2030
  • GERMANY
    • TABLE 38: Germany Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Germany 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2024 & 2030
    • TABLE 40: Germany Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 41: Germany 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2024 & 2030
  • ITALY
    • TABLE 42: Italy Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 43: Italy 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2024 & 2030
    • TABLE 44: Italy Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Italy 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2024 & 2030
  • UNITED KINGDOM
    • TABLE 46: UK Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 47: UK 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2024 & 2030
    • TABLE 48: UK Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 49: UK 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2024 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Rest of Europe 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2024 & 2030
    • TABLE 52: Rest of Europe Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 53: Rest of Europe 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2024 & 2030
  • ASIA-PACIFIC
    • Digital Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 54: Asia-Pacific Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 55: Asia-Pacific 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2024 & 2030
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2024 & 2030
  • REST OF WORLD
    • TABLE 58: Rest of World Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 59: Rest of World 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2024 & 2030
    • TABLE 60: Rest of World Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 61: Rest of World 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2024 & 2030

IV. COMPETITION